Table:
Tumour samples	Samples with decreased ABRO1 expression
Ratio of decreased samples	Average tumour/adjacent in decreased samples*
Hepatic cellular cancer	256/310 (83%)	0.39±0.21
Thyroid cellular cancer	21/31 (68%)	0.22±0.13
Breast cellular cancer	43/61 (70%)	0.61±0.17
Renal cellular cancer	97/136 (71%)	0.53±0.19

What are the following picture content in markdown style: | Tumour samples | <COLSPAN=2> Samples with decreased ABRO1 expression | 
 |  | Ratio of decreased samples | Average tumour/adjacent in decreased samples* |


 | --- | --- | --- | 
 | Hepatic cellular cancer | 256/310 (83%) | 0.39±0.21 | 
 | Thyroid cellular cancer | 21/31 (68%) | 0.22±0.13 | 
 | Breast cellular cancer | 43/61 (70%) | 0.61±0.17 | 
 | Renal cellular cancer | 97/136 (71%) | 0.53±0.19 |